What is the national unified selling price of Jisandai/Bingtongsha? How much does the patient need to pay out of pocket after being reimbursed by medical insurance?

Epclusa is a drug widely used in the treatment of hepatitis C (HCV). It contains two active ingredients: Sofosbuvir and Velpatasvir. This drug acts on the hepatitis C virus (HCV) itself through a direct antiviral mechanism, preventing the replication of the virus, helping patients clear the virus, reduce liver damage, and restore health. Jisandai is considered to be one of the revolutionary drugs for the treatment of hepatitis C. It has a broad antiviral spectrum and can treat different genotypes of hepatitis C virus, with a short treatment period and a high cure rate.

In China, Jisandai has been approved for marketing and has been included in the national medical insurance directory. According to the medical insurance policy, the price of Epclusa is relatively high. Each box is (400mg + 100mg) * 28 tablets, and the price is about more than 3,000 yuan. However, specific drug prices may vary by region, hospital pharmacy and sales channel.

It is worth mentioning that Jisandai has been included in medical insurance, but not all patients can directly enjoy full reimbursement from medical insurance. When patients enjoy medical insurance reimbursement, they usually need to bear certain out-of-pocket expenses based on their personal condition, treatment plan and the specific terms of the medical insurance policy. The specific out-of-pocket amount varies depending on the region and the specific reimbursement ratio of medical insurance. Some patients may need to pay part of the out-of-pocket portion, and medical insurance policies in some places may provide a higher reimbursement ratio, reducing the financial burden on patients.

In addition, for some patients, especially those from areas with more difficult economic conditions, generic drugs in countries such as India and Bangladesh have become another option. The price of these generic drugs is significantly lower than the original drugs, and the specifications are the same as the domestically marketed Jisandai, usually (400mg+100mg) * 28 tablets, and the price per box is about 800 yuan. Although there is a large price difference, generic drugs in India and Bangladesh have almost the same ingredients as the original drugs and can effectively treat hepatitis C, making them suitable for patients who cannot afford the high cost of drugs.

Reference: https://www.epclusa.com/